Loading...
Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism
Combining anticatabolic agents with parathyroid hormone (PTH) to enhance bone mass has yielded mixed results in osteoporosis patients. Toward the goal of enhancing the efficacy of these regimens, we tested their utility in combination with loss of the transcription factor Nmp4 because disabling this...
Na minha lista:
| Udgivet i: | Endocrinology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Endocrine Society
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659666/ https://ncbi.nlm.nih.gov/pubmed/28637206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2017-00355 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|